Antitrust Antitrust

Baxter, Hospira win dismissal of saline price-fixing suit

By Joshua Sisco
  • 06 Apr 2020 14:58
  • 06 Apr 2020 14:58
Medical companies Baxter and Hospira succeeded in permanently dismissing an antitrust case accusing them of fixing prices on intravenous saline solution through production quotas and product destruction.

In an opinion Friday, US District Judge John Tharp in Chicago dismissed the lawsuit for a second time, without giving the plaintiffs — a group of

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News